How Long Do PRP and Exosome Hair Results Last
How long do results last with PRP versus exosomes and how often are repeat treatments needed?
Neither of these treatments is a one-and-done purchase, and anyone selling you one that way is selling you the wrong expectation. Both buy you a window of better density that you then have to renew, which means you're budgeting for a program rather than a procedure. The useful question isn't which one lasts forever, it's how long each holds and what it costs you to keep it there.
Published follow-up in androgenetic alopecia shows PRP gains hold roughly six to twelve months after the last induction session before measurable regression toward baseline, which is why most clinicians schedule maintenance every three to six months.
How long do results typically last after a full PRP induction series?
The peak and the plateau are two different events, and confusing them is why people think their series failed at week ten. Hair grows about a centimeter a month, so follicles your first injection recruited aren't visible as new shafts for eight to twelve weeks. What follows the peak is a slow slide, not a cliff.
- Months 1 to 3: Recruited follicles are still below the surface, so you see little change even though the work is done.
- Months 4 to 6: Density peaks, with trials commonly reporting gains of 20 to 30 hairs per square centimeter.
- Month 9: A meaningful share of that gain is still there, but shed counts start creeping up in the shower.
- Month 12: Clear regression toward pretreatment values, though density generally sits above where you started.
Trichoscopic and phototrichogram counts commonly show a 20 to 30 hair per square centimeter gain at three to six months, much of it still present at nine months, with clear regression toward pretreatment values by twelve months in untreated patients.
How does the durability of exosome treatment compare with PRP over the same follow-up period?
Here's the part both camps tend to skip: the two treatments aren't backed by the same quality of evidence, so their durability numbers aren't the same kind of statement. A six-to-twelve-month PRP figure comes from trials that actually followed people that long. The same figure quoted for exosomes is often extrapolated from studies that stopped measuring at three or six months.
| Criteria | PRP | Exosomes |
|---|---|---|
| Evidence base | Controlled trials and systematic reviews, over a decade deep | Small case series, open-label reports, supplier data |
| Typical follow-up | Six to twelve months measured | Often stops at three to six months |
| Dose yardstick | Platelet concentration relative to whole blood | Particle counts rarely reported comparably |
| Product consistency | Varies by spin protocol, but one medicine | Varies by tissue source, isolation and quality control |
PRP has a measured six to twelve month durability window supported by controlled trials, while exosome durability rests largely on small case series that frequently stop measuring at three to six months.
What maintenance schedule do clinicians commonly use for PRP after the initial series?
Most programs land on a session every three to six months, and where you sit in that range should come from how your first year actually went. The usual pattern is one maintenance session at month six, then a reassessment with standardized photos and counts. Booking only after you can see loss in a photograph is the expensive way to do this, because recovering ground costs more sessions than holding it would have.
PRP maintenance is typically a single session every three to six months, but a lapse beyond roughly one year usually requires a fresh induction of two to three sessions rather than a single top-up.
How frequently are exosome sessions repeated and why do those protocols differ from PRP?
Exosome courses are shorter than PRP courses, and only part of that is biology. A typical program runs one to three sessions, then a repeat course six to twelve months later, against the near-universal three to four monthly sessions for PRP. Price is doing more of the work in that difference than most consultations admit.
- Course length: One to three sessions spaced four to twelve weeks apart, versus three to four for PRP.
- Cost pressure: Per-session prices often run two to three times PRP, so a four-session induction prices most patients out.
- Supplier protocols: Preparations differ in source tissue and particle concentration, and clinics usually follow the supplier's own guidance.
- The hybrid pattern: Some practices open with exosomes and maintain with PRP every three to six months, which is pragmatic rather than evidence-driven.
Exosome programs typically run one to three sessions spaced four to twelve weeks apart with a repeat course six to twelve months later, a compression driven as much by per-session costs of two to three times PRP as by pharmacology.
Why do regenerative hair treatment results fade instead of becoming permanent?
These treatments work downstream of the problem, not on it. Pattern loss comes from susceptible follicles converting testosterone to DHT and responding through the androgen receptor, which shortens the growth phase cycle after cycle. Nothing in a syringe of platelets or vesicles touches that signal.
- The burst: Roughly seventy percent of the platelet growth factor payload releases within ten minutes of activation, and essentially all of it inside an hour.
- The recruitment: Those signals push resting follicles into anagen, prolong that phase and drive new capillary formation around the follicle.
- The dissipation: The stimulus clears and the vascular improvements regress on a similar timescale once the angiogenic drive is gone.
- The resumption: Your follicles pick up the trajectory their receptors were always going to put them on.
About seventy percent of the platelet growth factor payload is released within ten minutes of activation and essentially all of it within an hour, so the months-long clinical effect comes from the hair cycle changes that burst triggered rather than from molecules persisting in the scalp.
Which patient factors make results last longer or fade faster?
Two people on identical protocols can be six months apart in when they need their next session, and most of that gap is you, not the treatment. Think of it as how much ground the treatment has to defend and how fast the opposing current is running. Several of the variables here are cheap to fix before you spend anything on injections.
Durability is driven most by how much viable miniaturized follicle remains at baseline, with early to mid-stage thinning holding gains substantially longer than advanced loss over slick scalp.
What happens to the scalp and hair count when maintenance treatments stop?
Patients brace for the wrong thing here. Stopping topical minoxidil produces a recognizable rebound shed because follicles held artificially in anagen synchronize into telogen and release together, and people assume injections behave the same way. They don't. What you get instead is a fade over roughly six to twelve months as recruited follicles finish their cycles and aren't re-recruited.
Stopping injectable maintenance produces a gradual six to twelve month drift back toward the untreated trajectory rather than a rebound shed, and a lapse beyond roughly one year typically requires a fresh induction of two to three sessions.
How do oral and topical hair medications change how often injections are needed?
Medication changes the arithmetic of maintenance more than anything else you control. An injection course pushes your density up but leaves the driver untouched, so the slope of decline between sessions doesn't change. A drug that flattens that slope means the same visible result holds on fewer visits.
| Criteria | 5-alpha reductase inhibitor | Topical minoxidil |
|---|---|---|
| What it does | Lowers scalp DHT, hitting the actual driver | Vasodilator and anagen prolonger |
| Effect on decline slope | Flattens it directly | Supports density, doesn't slow the process |
| Effect on your interval | Commonly holds results on fewer sessions | Extends intervals, less decisively |
| Best sequencing | Start well before the injection course so any initial shed resolves first | Can run alongside from the start |
A five-alpha reductase inhibitor lowers scalp dihydrotestosterone and flattens the rate of decline between sessions, so patients on stable DHT-blocking therapy commonly hold their result with fewer maintenance injections than they would otherwise need.
What does long term maintenance actually cost over three to five years for each option?
Comparing these on a single session price measures the wrong thing. The number that matters is the multi-year program, and the variable that moves it most isn't the sticker price at all, it's how often you need a session. That's why the medication question and your own patient factors have direct financial consequences.
A five-year PRP program plausibly totals eight thousand to twenty thousand dollars, built from a fifteen hundred to forty-five hundred dollar induction plus roughly one thousand to four thousand dollars of maintenance each year.
How reliable is the published evidence on how long these results last?
Every durability number in this field carries a quiet limitation, and it's a different limitation for each treatment. PRP's six-to-twelve-month figure can be stated with some confidence because randomized and split-scalp trials exist behind it, though the reviews keep flagging the same weaknesses. For exosomes, the regulatory position is part of why the evidence is thin: no exosome product is approved, and any exosome used to treat a condition is regulated as a drug and biological product subject to premarket review.
- Protocol standardization: Single versus double spin, leukocyte rich versus poor, activation or none, means pooling different medicines under one label.
- Follow-up length: A large share of trials stop at three or six months, and a treatment can't be shown to last twelve months by a study that ended at six.
- Sample size: Usually ten to sixty participants, enough to detect a density change, not enough to say who holds results.
- Measurement method: Global photographic assessment is subjective and flattering; trichoscopic counts are reproducible but sensitive to the exact scalp site.
No exosome product has regulatory approval for hair loss, and exosomes used to treat a disease or condition are regulated as drugs and biological products subject to premarket review and approval.
